AU Stock MarketDetailed Quotes

ATHO Alterity Therapeutics Ltd

Watchlist
  • 0.002
  • 0.0000.00%
20min DelayTrading Dec 2 13:37 AET
0Market Cap0.00P/E (Static)

Alterity Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Total revenue
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
35.20%19.4M
-5.19%14.35M
2.70%15.14M
9.45%14.74M
7.96%13.47M
12.47M
Selling and administrative expenses
-6.33%4.62M
-9.57%4.94M
-20.44%5.46M
105.85%6.86M
-22.09%3.33M
--4.28M
-General and administrative expense
-6.33%4.62M
-9.57%4.94M
-20.44%5.46M
105.85%6.86M
-22.09%3.33M
--4.28M
Research and development costs
41.26%18.64M
-10.49%13.2M
20.04%14.75M
21.64%12.28M
-22.22%10.1M
--12.98M
Depreciation amortization depletion
44.26%147.53K
88.63%102.26K
-28.07%54.21K
-32.96%75.37K
278.59%112.43K
--29.7K
-Depreciation and amortization
44.26%147.53K
88.63%102.26K
-28.07%54.21K
-32.96%75.37K
278.59%112.43K
--29.7K
Other taxes
-2.68%-4.02M
16.17%-3.91M
-13.16%-4.67M
---4.13M
--0
---4.95M
Other operating expenses
-80.81%5.24K
106.03%27.3K
-27.01%-452.96K
-354.24%-356.63K
-159.05%-78.51K
--132.97K
Operating profit
-35.20%-19.4M
5.19%-14.35M
-2.70%-15.14M
-9.45%-14.74M
-7.96%-13.47M
-12.47M
Net non-operating interest income (expenses)
1,533.12%268.42K
556.39%16.44K
-87.89%2.5K
20.79%20.68K
-84.23%17.12K
108.54K
Non-operating interest income
1,533.12%268.42K
556.39%16.44K
-87.89%2.5K
20.79%20.68K
-84.23%17.12K
--108.54K
Other net income (expenses)
-91.30%56.52K
-72.44%649.73K
498.72%2.36M
-7,432.00%-591.34K
-129.11%-7.85K
26.97K
Gain on sale of security
-72.06%261.15K
-65.66%934.8K
1,276.96%2.72M
-167.03%-231.31K
-1.14%345.07K
--349.06K
Other non-operating income (expenses)
28.22%-204.63K
21.83%-285.07K
-1.29%-364.67K
-2.01%-360.03K
-9.57%-352.92K
---322.1K
Income before tax
-39.23%-19.08M
-7.24%-13.7M
16.54%-12.78M
-13.77%-15.31M
-9.07%-13.46M
-12.34M
Income tax
-55.88%46.09K
49.21%104.46K
70.01K
0
0
0
Earnings from equity interest net of tax
Net income
-38.51%-19.12M
-7.47%-13.81M
16.08%-12.85M
-13.77%-15.31M
-9.07%-13.46M
-12.34M
Net income continuous operations
-38.51%-19.12M
-7.47%-13.81M
16.08%-12.85M
-13.77%-15.31M
-9.07%-13.46M
---12.34M
Noncontrolling interests
Net income attributable to the company
-38.51%-19.12M
-7.47%-13.81M
16.08%-12.85M
-13.77%-15.31M
-9.07%-13.46M
-12.34M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-38.51%-19.12M
-7.47%-13.81M
16.08%-12.85M
-13.77%-15.31M
-9.07%-13.46M
-12.34M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Total revenue 000000
Operating revenue --0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 35.20%19.4M-5.19%14.35M2.70%15.14M9.45%14.74M7.96%13.47M12.47M
Selling and administrative expenses -6.33%4.62M-9.57%4.94M-20.44%5.46M105.85%6.86M-22.09%3.33M--4.28M
-General and administrative expense -6.33%4.62M-9.57%4.94M-20.44%5.46M105.85%6.86M-22.09%3.33M--4.28M
Research and development costs 41.26%18.64M-10.49%13.2M20.04%14.75M21.64%12.28M-22.22%10.1M--12.98M
Depreciation amortization depletion 44.26%147.53K88.63%102.26K-28.07%54.21K-32.96%75.37K278.59%112.43K--29.7K
-Depreciation and amortization 44.26%147.53K88.63%102.26K-28.07%54.21K-32.96%75.37K278.59%112.43K--29.7K
Other taxes -2.68%-4.02M16.17%-3.91M-13.16%-4.67M---4.13M--0---4.95M
Other operating expenses -80.81%5.24K106.03%27.3K-27.01%-452.96K-354.24%-356.63K-159.05%-78.51K--132.97K
Operating profit -35.20%-19.4M5.19%-14.35M-2.70%-15.14M-9.45%-14.74M-7.96%-13.47M-12.47M
Net non-operating interest income (expenses) 1,533.12%268.42K556.39%16.44K-87.89%2.5K20.79%20.68K-84.23%17.12K108.54K
Non-operating interest income 1,533.12%268.42K556.39%16.44K-87.89%2.5K20.79%20.68K-84.23%17.12K--108.54K
Other net income (expenses) -91.30%56.52K-72.44%649.73K498.72%2.36M-7,432.00%-591.34K-129.11%-7.85K26.97K
Gain on sale of security -72.06%261.15K-65.66%934.8K1,276.96%2.72M-167.03%-231.31K-1.14%345.07K--349.06K
Other non-operating income (expenses) 28.22%-204.63K21.83%-285.07K-1.29%-364.67K-2.01%-360.03K-9.57%-352.92K---322.1K
Income before tax -39.23%-19.08M-7.24%-13.7M16.54%-12.78M-13.77%-15.31M-9.07%-13.46M-12.34M
Income tax -55.88%46.09K49.21%104.46K70.01K000
Earnings from equity interest net of tax
Net income -38.51%-19.12M-7.47%-13.81M16.08%-12.85M-13.77%-15.31M-9.07%-13.46M-12.34M
Net income continuous operations -38.51%-19.12M-7.47%-13.81M16.08%-12.85M-13.77%-15.31M-9.07%-13.46M---12.34M
Noncontrolling interests
Net income attributable to the company -38.51%-19.12M-7.47%-13.81M16.08%-12.85M-13.77%-15.31M-9.07%-13.46M-12.34M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -38.51%-19.12M-7.47%-13.81M16.08%-12.85M-13.77%-15.31M-9.07%-13.46M-12.34M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified OpinionUnqualified Opinion with Explanatory NotesUnqualified OpinionUnqualified OpinionUnqualified Opinion with Explanatory NotesUnqualified Opinion

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data